安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Apremilast - Wikipedia
Apremilast is indicated in the United States for the treatment of adults with active psoriatic arthritis, people with plaque psoriasis who are candidates for phototherapy or systemic therapy, and adults with oral ulcers associated with Behçet's disease
- Apremilast Uses, Dosage, Side Effects, Warnings - Drugs. com
Apremilast (Otezla) is a prescription medication used to treat plaque psoriasis, psoriatic arthritis, and mouth ulcers in Behcet's disease Apremilast improves the symptoms of plaque psoriasis, including scaling, itching, and skin redness, and reduces symptoms in the nails and scalp
- Apremilast (oral route) - Side effects dosage - Mayo Clinic
Apremilast is used to treat active psoriatic arthritis and oral ulcers caused by Behçet's disease It is also used to treat plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatment
- Otezla (apremilast) - Uses, Side Effects, and More - WebMD
Find patient medical information for Otezla (apremilast) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Apremilast: MedlinePlus Drug Information
Your doctor will probably start you on a low dose of apremilast and gradually increase your dose once every day for the first 5 days of treatment Apremilast controls psoriatic arthritis or plaque psoriasis, or treats oral ulcers, but does not cure them
- Apremilast - DermNet
Apremilast (Otezla®, Celgene) is an oral small- molecule inhibitor of the enzyme phosphodiesterase 4, which plays an important role in chronic inflammation associated with psoriasis
- Psoriasis treatment: Apremilast
Apremilast is a newer medicine that provides strong treatment for plaque psoriasis and psoriatic arthritis Unlike other strong medicines for psoriasis, you do not need to have medical tests while taking apremilast
- Apremilast (Otezla) - American College of Rheumatology
Apremilast (Otezla) is a prescription medicine that is approved to treat patients with psoriatic arthritis, moderate to severe plaque psoriasis, and the oral ulcers associated with Behçet's disease
|
|
|